Oliver Reuss is currently the Executive Director and Investment Manager at Boehringer Ingelheim Venture Fund and serves on the Board of Directors for multiple organizations including Dopavision, Brainomix, Aignostics, C-mo, and Glox. Oliver has held various roles at Boehringer Ingelheim since 2012, including Head of Business Model & HealthCare Innovation. Oliver completed a PhD in Molecular Biology at Bayerische Julius-Maximilians University of Würzburg, where they also earned a Diploma in Biology. They have experience as a Business Analyst at ZS Associates and a Postdoc at the same university, along with board memberships and committee roles in various biotech companies.
This person is not in the org chart
This person is not in any offices